Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Profit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Harvard Bioscience (HBIO) EPS (Weighted Average and Diluted) (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed EPS (Weighted Average and Diluted) for 16 consecutive years, with -$0.08 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) fell 1108.0% to -$0.08 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$0.08 through Dec 2025, down 1108.0% year-over-year, with the annual reading at -$1.29 for FY2025, 364.26% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.08 at Harvard Bioscience, down from -$0.05 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $0.06 in Q2 2022, with the low at -$0.17 in Q1 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.04, with a median of -$0.03 recorded in 2023.
  • The sharpest move saw EPS (Weighted Average and Diluted) skyrocketed 700.0% in 2022, then plummeted 1200.0% in 2024.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at $0.01 in 2021, then plummeted by 375.08% to -$0.04 in 2022, then grew by 6.83% to -$0.04 in 2023, then soared by 120.1% to $0.01 in 2024, then plummeted by 1108.0% to -$0.08 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at -$0.08, -$0.05, and $0.01 for Q4 2025, Q2 2025, and Q4 2024 respectively.